GlassScriptPhysician profile
James Hochrein
NPI 1467415166
$1,403.02
in general payments reported to CMS, 2019-2025
19 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $30.98 · 2021: $60.39 · 2022: $222 · 2023: $414 · 2024: $303 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $310.73 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $218.24 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $123.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $114.28 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $102.97 | 2021-2024 | |
| Abiomed | $101.44 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.75 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.14 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $45.54 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $41.07 | 2019-2024 | Eliquis |
| Irhythm Technologies, INC. | $38.59 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Cvrx, INC. | $38.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.42 | 2023 | |
| Portola Pharmaceuticals, LLC | $23.35 | 2019 | |
| Heartflow, INC. | $18.28 | 2023 | Ffrct |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $18.23 | 2023 | Injectafer |
| Novo Nordisk INC | $15.89 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $15.13 | 2024 | |
| Abbott Laboratories | $13.34 | 2023 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hochrein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.